Correlation Between 23Andme Holding and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Carmell Therapeutics, you can compare the effects of market volatilities on 23Andme Holding and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Carmell Therapeutics.
Diversification Opportunities for 23Andme Holding and Carmell Therapeutics
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between 23Andme and Carmell is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and Carmell Therapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Carmell Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, 23Andme Holding Co is 1.99 times less risky than Carmell Therapeutics. The stock trades about -0.09 of its potential returns per unit of risk. The Carmell Therapeutics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 46.00 in Carmell Therapeutics on September 12, 2024 and sell it today you would lose (23.89) from holding Carmell Therapeutics or give up 51.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Carmell Therapeutics
Performance |
| Timeline |
| 23Andme Holding |
| Carmell Therapeutics |
23Andme Holding and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Carmell Therapeutics
The main advantage of trading using opposite 23Andme Holding and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| Carmell Therapeutics vs. Sensient Technologies | Carmell Therapeutics vs. Hudson Technologies | Carmell Therapeutics vs. Xiabuxiabu Catering Management | Carmell Therapeutics vs. NL Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |